Published on in Vol 13, No 2 (2021): Apr-Jun
1 National Multiple Sclerosis Society, Cherry Hill, NJ, United States
2 Open Humans Foundation, San Diego, CA, United States
3 Novartis, Basel, Switzerland
4 Edgewise Therapeutics, Boulder, CO, United States
5 Parkinson’s UK, London, United Kingdom
6 National Academies of Sciences, Engineering, and Medicine, Washington, DC, United States
7 Parent Project Muscular Dystrophy, Bethesda, MD, United States
8 Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States
9 Biogen, Cambridge, MA, United States
10 Duke University School of Medicine, Durham, NC, United States
11 Bison Ink, Washington, DC, United States
12 Critical Path Institute, Tucson, AZ, United States
13 MJM Advisory, LLC, New York, NY, United States
14 Pancreatic Cancer Action Network, Washington, DC, United States
15 Doris Duke Charitable Foundation, New York, NY, United States
16 Global Healthy Living Foundation, Upper Nyack, NY, United States
17 Center for Open Science, Charlottesville, VA, United States
18 The Michael J Fox Foundation for Parkinson’s Research, New York, NY, United States
19 Department of Medicine, University of California San Francisco, San Francisco, CA, United States
20 Multiple Myeloma Research Foundation, Norwalk, CT, United States
21 Vivli, Columbia, MO, United States
22 Genetic Alliance, Washington, DC, United States